Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 910 of 1,261
  1. US 8247410

    Pyrimidine substituted purine derivatives

    VERASTEM, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  2. US 8247420

    Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents

    REVIVA PHARMACEUTICALS, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  3. US 8247433

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  4. US 8247429

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  5. US 8247399

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  6. US 8247225

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  7. US 8247393

    Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  8. US 8247181

    Borrelia diagnostics and screening methods

    The Regents of the University of California · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  9. US 8246984

    Formulation of insoluble small molecule therapeutics in lipid-based carriers

    Rigel Pharmaceuticals, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  10. US 8246983

    Encapsulated arsenic drugs

    Northwestern University · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  11. US 8246971

    Compositions containing aromatic aldehydes and their use in treatment

    SkinMedica, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  12. US 8247174

    Methods of diagnosing endometriosis

    The Regents of the University of California · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  13. US 8246987

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  14. US 8247564

    Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  15. US 8247532

    Deuterated hepatitis C protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  16. US 8247228

    Method of inducing memory B cell development and terminal differentiation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  17. US 8247183

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  18. US 8241638

    Induction of an immune response against dengue virus using the prime-boost approach

    United States of America as represented by the Secretary of the Air Force · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  19. US 8242145

    Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  20. US 8242160

    Inhibitors of ubiquitin E1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  21. US 8242170

    Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy

    The Regents of the University of California · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  22. US 8242093

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  23. US 8242272

    Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  24. US 8242080

    Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface

    The Regents of the University of California · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.